🔗 Share this article

A shadow market for unapproved weight-loss medications is being driven by social media fitness personalities and vendors on communication apps, based on recent findings.

Experimental Drug Gaining Popularity Online

The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged fat-burning properties. Viewers are encouraged to contact these profiles privately for source information, while also receiving discount codes.

Active Commerce on Social Networks

Additionally, a flourishing market exists on Telegram, where groups with numerous of participants share “before and after” images, injection guides and claims of next-day UK delivery. Vendors promote the drug there before redirecting customers to other platforms for transactions.

Understanding Retatrutide

Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Experts Voice Worries

Nevertheless, physicians and pharmacists have cautions that the sale of what is still an unapproved medication in the United Kingdom is a cause for concern and could lead to users administering substances of unknown origin.

Some professionals said the popularity for retatrutide could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.

Legal Status and Enforcement

Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be marketed or supplied for human use under the British medical regulations.

Several influencers attempt to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still violate medicines, advertising, and consumer laws, potentially leading to penalties, prosecution or imprisonment.

Platform Response and Material Elimination

According to the social media company, the platform has taken down problematic content and prohibited associated hashtags and search suggestions. The company said it was dedicated to maintaining the platform secure and investing in enhancing compliance measures.

Online Marketplace Activities

Investigations also discovered groups with up to 9,000 participants marketing retatrutide using Telegram's built-in search feature, which operates like a online catalog. Typing “retatrutide” instantly displays channels with thousands of users, filled with photos of weight loss, positive testimonials and detailed instructions for mixing or administering at residence.

After minutes of joining one group, a seller shared WhatsApp details, where most purchases occur. The seller provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one asked about body mass, health issues or past usage.

Product Information and Pricing

Within these groups, messages display dark colored parcels with postal service labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled injectors usually sold at £160 for 20 milligrams. When questioned how long a injector should be used, vendors give conflicting answers varying between a several days to “depends on your body”.

Service Oversight and Safety Actions

A spokesperson for the messaging service said it actively moderated dangerous content on its service including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are administering materials they cannot confirm. Although the research behind retatrutide is valid, these online versions may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the increase in interest to recent cost increases for authorized slimming medications such as Mounjaro. “With costs rising, patients are using online platforms. But counterfeit injections are highly risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she explained.

Her staff has previously seen patients harmed by self-injection from unverified sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a company investigational product not yet approved … may subject patients to potentially significant health risks”.